Page last updated: 2024-08-18

acrylonitrile and Disease Exacerbation

acrylonitrile has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boulinguez, S; Lamant, L; Lucas, P; Meyer, N; Mourey, L; Paul, C; Sibaud, V	1

Other Studies

1 other study(ies) available for acrylonitrile and Disease Exacerbation

Article	Year
Characterization and Outcomes of Disease Progression in 52 Patients Treated with BRAF-V600 + MEK Inhibitors for Advanced Melanoma. Dermatology (Basel, Switzerland), 2018, Volume: 234, Issue:3-4 Topics: Acrylonitrile; Aged; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Disease Progression; Female; Humans; Male; MAP Kinase Kinase 1; Melanoma; Middle Aged; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Vemurafenib	2018

Article

Year

Characterization and Outcomes of Disease Progression in 52 Patients Treated with BRAF-V600 + MEK Inhibitors for Advanced Melanoma.

Dermatology (Basel, Switzerland), 2018, Volume: 234, Issue:3-4

Topics: Acrylonitrile; Aged; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Disease Progression; Female; Humans; Male; MAP Kinase Kinase 1; Melanoma; Middle Aged; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Vemurafenib

2018